Related Experiment Videos
Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity
1III. Medizinische Klinik und Poliklinik, Universität Giessen, Federal Republic of Germany.
Clinical Immunology and Immunopathology
|August 1, 1990
Summary
CD5+ B cells correlate with disease activity in rheumatoid arthritis and type I diabetes, and are influenced by corticosteroid therapy in RA. Their role in systemic lupus erythematosus appears minimal.
Area of Science:
- Immunology
- Autoimmunity
- B cell biology
Background:
- CD5+ B cells are a distinct B cell subset implicated in autoimmune diseases.
- Understanding their role is crucial for managing autoimmune conditions.
Purpose of the Study:
- To investigate the association between CD5+ B cell levels and disease activity in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and type I diabetes.
- To explore the impact of therapy on CD5+ B cell populations.
Main Methods:
- Flow cytometry to quantify CD5+ B cells.
- Measurement of autoantibodies (rheumatoid factor, antinuclear antibodies, anti-islet cell antibodies).
- Assessment of C-reactive protein (CRP) as a marker of inflammation.
Main Results:
- In RA, CD5+ B cells correlated with autoantibodies and CRP; corticosteroid treatment significantly altered their numbers.
- SLE patients showed slightly elevated CD5+ B cells, but without a strong link to disease activity.
- CD5+ B cells were present in type I diabetes patients with anti-islet cell antibodies.
Conclusions:
- CD5+ B cells are linked to autoimmune disease activity and therapy response in RA.
- CD5+ B cells may not play a major role in SLE, but could be affected by polyclonal activation.
- Further research is needed to clarify the role of CD5+ B cells in organ-specific autoimmunity.